Emergent BioSolutions, Inc. (EBS)

Last Three Months

01-Jan-23 -- 31-Mar-23

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

29

0

6

+1

0

+2

0

+3

Two Year Chart

01-Apr-21 -- 31-Mar-23

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Mar-23 2:42 PM View:	28-Feb-23 Payment of Exercise ($8.54K)	Strei Katherine EVP, Chief HR Officer		Emergent BioSolutions, Inc. - EBS	(5%) 65.9K to 62.82K	0	0	--	--	Show Txns Hide Txns

06-Mar-23 7:37 PM View:	02-Mar-23 Grant 0	Havey Adam EVP, Business Operations		Emergent BioSolutions, Inc. - EBS	173% 36.79K to 100.55K	0	0	--	--	Show Txns Hide Txns

06-Mar-23 7:36 PM View:	02-Mar-23 Grant 0	Lindahl Richard S EVP, Chief Financial Officer		Emergent BioSolutions, Inc. - EBS	357% 21.7K to 99.14K	0	0	--	--	Show Txns Hide Txns

06-Mar-23 7:37 PM View:	02-Mar-23 Grant 0	Kramer Robert President and CEO Director		Emergent BioSolutions, Inc. - EBS	157% 114.21K to 293.75K	0	0	--	--	Show Txns Hide Txns

02-Mar-23 2:43 PM View:	28-Feb-23 Payment of Exercise ($12.02K)	Saran Atul EVP, Chief Strat & Dev Officer		Emergent BioSolutions, Inc. - EBS	(5%) 90.78K to 86.64K	0	0	--	--	Show Txns Hide Txns

06-Mar-23 7:35 PM View:	02-Mar-23 Grant 0	Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec		Emergent BioSolutions, Inc. - EBS	19% 88.39K to 105.36K	0	0	--	--	Show Txns Hide Txns

06-Mar-23 7:36 PM View:	02-Mar-23 Grant 0	Glessner Coleen EVP, Quality & Ethics, and CPL		Emergent BioSolutions, Inc. - EBS	11% 108.14K to 119.67K	0	0	--	--	Show Txns Hide Txns

06-Mar-23 7:36 PM View:	02-Mar-23 Grant 0	Williams Paul Anthony SVP, Products Business		Emergent BioSolutions, Inc. - EBS	32% 9.38K to 12.38K	0	0	--	--	Show Txns Hide Txns